Werner Baumann, Bayer CEO (Malte Ossowski/SVEN SIMON/picture-alliance/dpa/AP Images)

Bay­er CEO Wern­er Bau­mann says com­pa­ny is 'putting ma­jor lit­i­ga­tion be­hind us' while high­light­ing Q2 growth

Bay­er CEO Wern­er Bau­mann high­light­ed “strong op­er­a­tional per­for­mance” on Thurs­day while rais­ing the full-year guid­ance. But be­fore div­ing in­to the de­tails, he sum­ma­rized Bay­er’s plan to set­tle a slate of on­go­ing lit­i­ga­tion.

“We are mak­ing good progress in putting ma­jor lit­i­ga­tion be­hind us,” Bau­mann said on a Q2 call with in­vestors and an­a­lysts.

He added that the com­pa­ny is “con­fi­dent in the lit­i­ga­tion strat­e­gy” when it comes to glyphosate, the ac­tive in­gre­di­ent in the weed­killer Roundup. Bay­er has faced mul­ti­ple cas­es al­leg­ing that Roundup caused can­cer, and re­cent­ly an­nounced a five-point plan to “a clear path to clo­sure of the U.S. glyphosate lit­i­ga­tion.”

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.